Finance

Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)

AC
Alex Chen
Tech Journalist & Product Reviewer
Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)
Image source: finance.yahoo.com

Thermo Fisher Scientific Inc. (TMO) Sees 12% Upside

Analysts' Forecast

Analysts at finance.yahoo.com [6] have forecasted a 12% upside to Thermo Fisher Scientific Inc. (TMO). This prediction is based on the company's current market performance and future growth prospects.

Market Performance

Thermo Fisher Scientific Inc. (TMO) has been performing well in the market, with its stock price increasing over the past few months. The company's strong financials and innovative products have contributed to its success.

Analysts' Recommendations

Analysts at finance.yahoo.com [6] have recommended buying Thermo Fisher Scientific Inc. (TMO) due to its strong growth prospects and competitive advantage. They believe that the company's products will continue to drive growth in the biotechnology and healthcare industries.

Conclusion

Thermo Fisher Scientific Inc. (TMO) is a strong investment opportunity due to its 12% upside forecast. Analysts believe that the company's innovative products and strong financials will continue to drive growth in the biotechnology and healthcare industries.

Sources

[1] Where Will Broadcom Stock Be in 1 Year?
[2] Ethereum Leads Wall Street Tokenization Race as Mass Adoption Looms
[3] Google was at risk of losing its dominance — until it promoted this AI executive
[4] How Build-A-Bear went from a penny stock to a retail winner
[5] My husband and I are splitting our estate between his child and my three children. Should they get equal shares?
[6] Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)
[7] Oracle Corporation (ORCL) a Moderate Buy, Per Wall Street Analysts
[8] Analysts Forecast 9% Upside To Capital One Financial Corporation (COF)
[9] Wall Street Remains Bullish on Mastercard Incorporated (MA)
[10] Wolfe Research Cuts Netflix, Inc. (NFLX)’s Price Target To $121, Maintains Outperform Rating